PBAC Outcomes by Meeting
Recommendation made by the extraordinary PBAC meeting - March 2006
Recommendation made by the Pharmaceutical Benefits Advisory Committee (PBAC) at an extraordinary March 2006 Meeting relating to the listing of Insulin glargine on the Pharmaceutical Benefits Scheme (PBS)
To search for a drug name by keyword it is suggested that you use your browser's 'Find' function (Control-F or Edit, Find in most browsers).
March 2006 Extraordinary Meeting PBAC Outcomes - Positive Recommendation
Drug and Form
Drug Use and Type
Listing Requested by Sponsor
|Insulin glargine, injection, 100 units per mL, |
10 mL vials and 3 mL x 5 cartridges,
|Treatment for diabetes||Unrestricted listing||The PBAC recommended the listing of insulin glargine as an unrestricted benefit on the basis that the clinical benefit over NPH insulin (improvement in hypoglycaemic event rates) in a population which cannot be defined effectively, but which is likely to include those with a high level of need, was cost-effective at the new price proposed.|
|Sponsor’s comments||Sanofi-aventis is pleased that we have been able to reach agreement with the PBAC. The efforts of both PBAC and sanofi-aventis have been in good faith and we look forward to the positive recommendation of the PBAC being accepted by the Government in the near future.|
When accessing large documents (over 500 KB in size), it is recommended that the following procedure be used:
- Click the link with the RIGHT mouse button
- Choose "Save Target As.../Save Link As..." depending on your browser
- Select an appropriate folder on a local drive to place the downloaded file
Attempting to open large documents within the browser window (by left-clicking)
may inhibit your ability to continue browsing while the document is
opening and/or lead to system problems.
To view PDF (Portable Document Format) documents, you will need to have a PDF reader installed on your computer. A number of PDF readers are available through the Australian Government Information Management Office (AGIMO) Web Guide website.